Pfizer’s $8 Billion Gene Therapy Buyout Sparks Biotech Frenzy
On March 21, 2025, Pfizer ignited the biotech world with an $8 billion buyout of Sangamo Therapeutics, a gene-editing pioneer, aiming to dominate next-gen treatments. Announced at a New York investor call and covered by Reuters and BioPharma Dive, this…